Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000950243 | SCV000531881 | likely benign | not provided | 2020-10-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000950243 | SCV001096533 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000950243 | SCV002063440 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | ALPK3: BP4, BP7, BS2 |
Ambry Genetics | RCV002436337 | SCV002751348 | benign | Cardiovascular phenotype | 2019-01-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004533097 | SCV004732408 | likely benign | ALPK3-related disorder | 2019-02-21 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000425056 | SCV001917450 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000950243 | SCV001976111 | likely benign | not provided | no assertion criteria provided | clinical testing |